Bridgewater Associates’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
HHAM
Bridgewater Associates's ADNT Position: Q2 2026 in Review
Bridgewater Associates increased its Adient (ADNT) stake by 31% in Q2 2026, buying an estimated $1.9M and bringing the position to 378,873 shares worth $6.96M. The position accounts for 0.03% of the portfolio, ranked #407.
Bridgewater Associates first reported a position in ADNT in Q4 2019 and has held it in 14 quarters since. The position peaked at $10.4M in Q3 2025. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.
- Bridgewater Associates held 378,873 shares of Adient worth $6.96M as of Q2 2026.
- Bridgewater Associates bought 88,774 Adient shares in Q2 2026, an estimated $1.9M.
- Adient made up 0.03% of Bridgewater Associates's portfolio in Q2 2026, its #407 holding.
- Bridgewater Associates first reported a position in Adient in Q4 2019 and has held it in 14 quarters since.
- Bridgewater Associates's Adient position peaked at $10.4M in Q3 2025.
- 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.